Cargando…

Evaluation and Validation of Plasma Proteins Using Two Different Protein Detection Methods for Early Detection of Colorectal Cancer

Objective: Plasma protein biomarkers could be an efficient alternative for population-based screening for early detection of colorectal cancer (CRC). The objective of this study was to evaluate and validate plasma proteins individually and as a signature for early detection of CRC. Methods: In a thr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhardwaj, Megha, Gies, Anton, Weigl, Korbinian, Tikk, Kaja, Benner, Axel, Schrotz-King, Petra, Borchers, Christoph H., Brenner, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826652/ https://www.ncbi.nlm.nih.gov/pubmed/31557860 http://dx.doi.org/10.3390/cancers11101426

Ejemplares similares

Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer
por: Bhardwaj, Megha, et al.
Publicado: (2019)

Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017)

Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review
por: Erben, Vanessa, et al.
Publicado: (2018)

Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer
por: Bhardwaj, Megha, et al.
Publicado: (2021)

Potential of Inflammatory Protein Signatures for Enhanced Selection of People for Lung Cancer Screening
por: Bhardwaj, Megha, et al.
Publicado: (2022)

Correlation of Repeat Measurements of 27 Candidate Protein Markers for Colorectal Cancer Screening Taken Three Years and Multiple Freeze–Thaw Cycles Apart
por: Bhardwaj, Megha, et al.
Publicado: (2022)

Cell Line Secretome and Tumor Tissue Proteome Markers for Early Detection of Colorectal Cancer: A Systematic Review
por: Bhardwaj, Megha, et al.
Publicado: (2017)

Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis
por: Qian, Jing, et al.
Publicado: (2018)

Consistent Major Differences in Sex- and Age-Specific Diagnostic Performance among Nine Faecal Immunochemical Tests Used for Colorectal Cancer Screening
por: Gies, Anton, et al.
Publicado: (2021)

Fecal Immunochemical Tests Detect Screening Participants with Multiple Advanced Adenomas Better than T1 Colorectal Cancers
por: Gies, Anton, et al.
Publicado: (2021)

Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening
por: Gies, Anton, et al.
Publicado: (2018)

Combination of Different Fecal Immunochemical Tests in Colorectal Cancer Screening: Any Gain in Diagnostic Performance?
por: Gies, Anton, et al.
Publicado: (2019)

Fecal microRNAs, Fecal microRNA Panels, or Combinations of Fecal microRNAs with Fecal Hemoglobin for Early Detection of Colorectal Cancer and Its Precursors: A Systematic Review
por: Zhao, Zitong, et al.
Publicado: (2021)

Fecal Immunochemical Tests for Colorectal Cancer Screening: Is Fecal Sampling from Multiple Sites Necessary?
por: Amitay, Efrat L., et al.
Publicado: (2019)

Assessment of a Serum Microrna Risk Score for Colorectal Cancer among Participants of Screening Colonoscopy at Various Stages of Colorectal Carcinogenesis
por: Raut, Janhavi R., et al.
Publicado: (2022)

Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review
por: Raut, Janhavi R., et al.
Publicado: (2020)

Study protocol of the RaPS study: novel risk adapted prevention strategies for people with a family history of colorectal cancer
por: Tikk, Kaja, et al.
Publicado: (2018)

Accuracy of a fecal immunochemical test according to outside temperature and travel time
por: Niedermaier, Tobias, et al.
Publicado: (2018)

A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction
por: Raut, Janhavi R., et al.
Publicado: (2021)

Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review
por: Niedermaier, Tobias, et al.
Publicado: (2016)

Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms
por: Tikk, Kaja, et al.
Publicado: (2018)

Impact of Inadequate Bowel Cleansing on Colonoscopic Findings in Routine Screening Practice
por: Niedermaier, Tobias, et al.
Publicado: (2020)

Prognostic Value of Post-Operative C-Reactive Protein-Based Inflammatory Biomarkers in Colorectal Cancer Patients: Systematic Review and Meta-Analysis
por: Gwenzi, Tafirenyika, et al.
Publicado: (2023)

Comparing Metabolomics Profiles in Various Types of Liquid Biopsies among Screening Participants with and without Advanced Colorectal Neoplasms
por: Erben, Vanessa, et al.
Publicado: (2021)

Whole-blood DNA Methylation Markers for Risk Stratification in Colorectal Cancer Screening: A Systematic Review
por: Raut, Janhavi R., et al.
Publicado: (2019)

Variation of Positive Predictive Values of Fecal Immunochemical Tests by Polygenic Risk Score in a Large Screening Cohort
por: Niedermaier, Tobias, et al.
Publicado: (2022)

Vitamin D Status, Cdx2 Genotype, and Colorectal Cancer Survival: Population-Based Patient Cohort
por: Gwenzi, Tafirenyika, et al.
Publicado: (2023)

Effects of Alternative Offers of Screening Sigmoidoscopy and Colonoscopy on Utilization and Yield of Endoscopic Screening for Colorectal Neoplasms: Protocol of the DARIO Randomized Trial
por: Schrotz-King, Petra, et al.
Publicado: (2020)

Flexible sigmoidoscopy in colorectal cancer screening: implications of different colonoscopy referral strategies
por: Niedermaier, Tobias, et al.
Publicado: (2018)

A serum microRNA signature for enhanced selection of people for lung cancer screening
por: Yu, Haixin, et al.
Publicado: (2022)

Age-specific sequence of colorectal cancer screening options in Germany: A model-based critical evaluation
por: Heisser, Thomas, et al.
Publicado: (2020)

Risk Scores for Predicting Advanced Colorectal Neoplasia in the Average‐risk Population: A Systematic Review and Meta‐analysis
por: Peng, Le, et al.
Publicado: (2018)

Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening
por: Peng, Le, et al.
Publicado: (2019)

Evaluation of different stool extraction methods for metabolomics measurements in human faecal samples
por: Erben, Vanessa, et al.
Publicado: (2021)

Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer
por: Luo, Xiaoya, et al.
Publicado: (2013)

Genotype-Based Gene Expression in Colon Tissue—Prediction Accuracy and Relationship with the Prognosis of Colorectal Cancer Patients
por: Deutelmoser, Heike, et al.
Publicado: (2020)

Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score
por: Weigl, Korbinian, et al.
Publicado: (2018)

Head-to-Head Comparison of Family History of Colorectal Cancer and a Genetic Risk Score for Colorectal Cancer Risk Stratification
por: Weigl, Korbinian, et al.
Publicado: (2019)

Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer
por: Chen, Hongda, et al.
Publicado: (2017)

Polymorphisms in the Angiogenesis-Related Genes EFNB2, MMP2 and JAG1 Are Associated with Survival of Colorectal Cancer Patients
por: Scherer, Dominique, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5dd8mndgt1fj6bvp4m6fv1vk5n